Table 5 |
||||||||||||
|
Cancer risks (standardized incidence ratios SIR) in women with residence in communities with planted winegrowing areas with the estimated incidence of cancer in the national population of Germany as reference |
||||||||||||
|
Area under wine cultivation > 0, ≤ 5% of community area (1,665,594 PY†) |
Area under wine cultivation > 5, ≤ 20% of community area (1,039,435 PY†) |
Area under wine cultivation > 20% of community area (612,714 PY†) |
||||||||||
|
|
||||||||||||
|
ICD-10 code |
Observed |
Expected |
SIR |
95% CI |
Observed |
Expected |
SIR |
95% CI |
Observed |
Expected |
SIR |
95% CI |
|
|
||||||||||||
|
Head & neck (C00–C14) |
123 |
93.17 |
1.32 |
1.10–1.58 |
70 |
57.01 |
1.23 |
0.96–1.55 |
41 |
31.13 |
1.32 |
0.95–1.79 |
|
Stomach (C16) |
197 |
302.45 |
0.65 |
0.56–0.75 |
147 |
183.37 |
0.80 |
0.68–0.94 |
61 |
96.98 |
0.63 |
0.48–0.81 |
|
Colon, sigmoid & rectum (C18–C21) |
1122 |
1529.06 |
0.73 |
0.69–0.78 |
733 |
929.83 |
0.79 |
0.73–0.85 |
346 |
491.03 |
0.70 |
0.63–0.78 |
|
Trachea, bronchus and lung (C33–C34) |
342 |
429.49 |
0.80 |
0.71–0.89 |
168 |
263.51 |
0.64 |
0.54–0.74 |
94 |
142.96 |
0.66 |
0.53–0.80 |
|
Skin, malignant melanoma (C43) |
274 |
314.29 |
0.87 |
0.77–0.98 |
212 |
191.68 |
1.11 |
0.96–1.27 |
109 |
107.56 |
1.01 |
0.83–1.22 |
|
Breast (C50) |
2525 |
2332.19 |
1.08 |
1.04–1.13 |
1527 |
1429.33 |
1.07 |
1.02–1.12 |
779 |
786.82 |
0.99 |
0.92–1.06 |
|
Cervix uteri (C53) |
162 |
239.01 |
0.68 |
0.58–0.79 |
97 |
145.48 |
0.67 |
0.54–0.81 |
47 |
83.17 |
0.57 |
0.42–0.75 |
|
Corpus uteri, (C54–C55) |
382 |
309.64 |
1.23 |
1.11–1.36 |
244 |
190.05 |
1.28 |
1.13–1.46 |
146 |
102.37 |
1.43 |
1.20–1.68 |
|
Ovary and other unspecified female genital organs (C56–C57) |
297 |
449.08 |
0.66 |
0.59–0.74 |
196 |
273.91 |
0.72 |
0.62–0.82 |
96 |
149.12 |
0.64 |
0.52–0.79 |
|
Urinary tract (C64-C66+C68) |
208 |
261.56 |
0.80 |
0.69–0.91 |
136 |
160.51 |
0.85 |
0.71–1.00 |
73 |
86.15 |
0.85 |
0.66–1.07 |
|
Bladder (C67, D09.0, D41.4) |
251 |
325.54 |
0.77 |
0.68–0.87 |
158 |
200.30 |
0.79 |
0.67–0.92 |
85 |
107.82 |
0.79 |
0.63–0.97 |
|
NHL (C82–C85) |
220 |
286.04 |
0.77 |
0.67–0.88 |
114 |
175.38 |
0.65 |
0.54–0.78 |
52 |
95.33 |
0.55 |
0.41–0.72 |
|
Leukaemia (C91–C95) |
135 |
228.14 |
0.59 |
0.50–0.70 |
65 |
139.57 |
0.47 |
0.36–0.59 |
43 |
75.32 |
0.57 |
0.41–0.77 |
|
All malignancies (excluding C44) |
7258 |
8285.78 |
0.88 |
0.86–0.90 |
4508 |
5070.41 |
0.89 |
0.86–0.92 |
2293 |
2740.00 |
0.84 |
0.80–0.87 |
|
|
||||||||||||
|
† PY: Person-Years were approximated by population figures: the sum of population at the end of the year in the years under consideration. |
||||||||||||
|
Seidler et al. Journal of Occupational Medicine and Toxicology 2008 3:12 doi:10.1186/1745-6673-3-12 |
||||||||||||
